PINK1 and myeloid neoplasm: Furthermore, chloroquine and Lys05, which target autophagy downstream of PINK1, also preferentially kill SRSF2P95H/+ cells, supporting the hypothesis that these splicing factor mutant cells are dependent on mitophagy for survival and suggesting an actionable therapeutic target in splicing factor mutant myeloid neoplasms.